<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01895413</url>
  </required_header>
  <id_info>
    <org_study_id>CTM_LESÃO ARTICULAR-461/2010</org_study_id>
    <secondary_id>CTM_LESÃO ARTICULAR-461/2010</secondary_id>
    <nct_id>NCT01895413</nct_id>
  </id_info>
  <brief_title>Autologous Bone Marrow Mesenchymal Stem Cells Transplantation for Articular Cartilage Defects Repair</brief_title>
  <official_title>Autologous Bone Marrow-derived Mesenchymal Stem Cells Used in the Treatment of Articular Cartilage Injury</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Alexandra Cristina Senegaglia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Pontifícia Universidade Católica do Paraná</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Consultório Médico Dr. Alcy Vilas Boas Jr., Paraná, Brasil</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital Marcelino Champagnat, Paraná, Brasil</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Fundação Araucária</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Pontifícia Universidade Católica do Paraná</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a non-randomized study aimed to determine the safety and efficacy of intra-articular
      injection of autologous bone marrow-derived mesenchymal stem cells in patients with knee
      articular cartilage defects.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Osteoarthritis is the most prevalent joint disease, create articular cartilage defects is a
      frequent cause of joint pain, functional loss, and disability. Osteoarthritis often becomes
      chronic, and conventional treatments seek to ameliorate pain or improve mobility. However,
      these treatments rarely modify the course of the disease.Recent studies cell-based have shown
      encouraging results in both animal studies and a few human case reports. We designed a study
      to assess the safety and efficacy of osteoarthritis treatment with intra-articular injection
      of autologous bone marrow-derived mesenchymal stem cells.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2012</start_date>
  <completion_date type="Actual">January 2016</completion_date>
  <primary_completion_date type="Actual">July 2013</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in WOMAC (Western Ontario and McMaster Universities)score</measure>
    <time_frame>3 months, 6 months, 9 months, 12 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in cartilage thickness at 6 months by MRI</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Knee pain relief (WOMAC and Lequesne scores)</measure>
    <time_frame>3 months, 6 months, 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in progression of osteoarthritis at 12 months by plain radiograph (X-ray)</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">10</enrollment>
  <condition>Osteoarthritis</condition>
  <arm_group>
    <arm_group_label>Mesenchymal stem cells</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Bone marrow aspiration, Autologous bone marrow-derived mesenchymal stem cells</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Bone marrow aspiration</intervention_name>
    <description>Single intra-articular injection of autologous bone marrow-derived mesenchymal stem cells by arthroscopy</description>
    <arm_group_label>Mesenchymal stem cells</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosed with mild to moderate osteoarthritis (visual analogue scale)

          -  History of joint swelling, pain, stiffness, altered gait and loss of motion due to
             degenerative cartilage

        Exclusion Criteria:

          -  Any past history of neoplasia and primary hematological disease

          -  Autoimmune disease or the medical history

          -  Systemic bone or cartilage disorders

          -  Acute or chronic communicable diseases including Hepatitis B, Hepatitis C and HIV

          -  Co-morbidity which the physician deems as a contraindication to stem cell
             transplantation and bone marrow biopsy

          -  Evidence of infection or fractures in or around the joint

          -  Contraindication to bone marrow aspiration

          -  Deviation from the axial axis (varus or valgus) greater than 12 degrees.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Paulo Brofman, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Pontifícia Universidade Católica do Paraná</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Centro de Tecnologia Celular, Pontifícia Universidade Católica do Paraná</name>
      <address>
        <city>Curitiba</city>
        <state>Paraná</state>
        <zip>80215-901</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>October 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 1, 2013</study_first_submitted>
  <study_first_submitted_qc>July 4, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 10, 2013</study_first_posted>
  <last_update_submitted>December 11, 2017</last_update_submitted>
  <last_update_submitted_qc>December 11, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 13, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Pontifícia Universidade Católica do Paraná</investigator_affiliation>
    <investigator_full_name>Alexandra Cristina Senegaglia</investigator_full_name>
    <investigator_title>PhD</investigator_title>
  </responsible_party>
  <keyword>Cartilage injury</keyword>
  <keyword>Osteoarthritis</keyword>
  <keyword>Mesenchymal stem cells</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

